IDH1 mutations in a Brazilian series of Glioblastoma

Clinics

Volumn 66, Issue 1, 2011, Pages 163-165

  Uno, Miyuki ^a   Oba Shinjo, Sueli Mieko ^a   da Silva, Roseli ^a   Miura, Flavio ^a   Clara, Carlos Afonso ^c   de Almeida, José Reynaldo Walther ^c   Malheiros, Suzana M F ^d   Bianco, André Macedo ^e   Brandt, Reynaldo ^f   Ribas, Guilherme Carvalhal ^f   Feres, Halim ^f   Dzik, Carlos ^b   Rosemberg, Sérgio ^a   Stavale, João Norberto ^d   Teixeira, Manoel Jacobsen ^a   Marie, Suely K N ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Sao Paulo Cancer Institute   (Brazil)

^c BARRETOS CANCER HOSPITAL   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e Hospital Nove de Julho   (Brazil)

^f HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCITRATE DEHYDROGENASE;

ADULT; ARTICLE; BRAIN TUMOR; BRAZIL; FEMALE; GENE FREQUENCY; GENETICS; GLIOBLASTOMA; HUMAN; MALE; METASTASIS; MIDDLE AGED; POINT MUTATION;

ADULT; BRAIN NEOPLASMS; BRAZIL; FEMALE; GENE FREQUENCY; GLIOBLASTOMA; HUMANS; ISOCITRATE DEHYDROGENASE; MALE; MIDDLE AGED; POINT MUTATION;

EID: 79952971590     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000100028     Document Type: Article

References (16)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109, doi: 10.1007/s00401-007-0243-4.
2. von Deimling A, Louis DN, Schramm J, Wiestler OD. Astrocytic gliomas: characterization on a molecular genetic basis. Recent Results Cancer Res. 1994:33-42.
3. Korshunov A, Sycheva R, Golanov A. The prognostic relevance of molecular alterations in glioblastomas for patients age, 50 years. Cancer. 2005;104:825-32, doi: 10.1002/cncr.21221.
4. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 2008;116:597-602, doi: 10.1007/s00401-008-0455-2.
5. Ichimura K, Pearson DM, Kocialkowski S, Bäcklund LM, Chan R, Jones DT, et al. IDH1 mutations are present in the majority of common adult gliomas but are rare in primary glioblastomas. Neurol Oncol. 2009;11: 341-7, doi: 10.1215/15228517-2009-025.
6. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol. 2009;174:1149-53, doi: 10.2353/ajpath.2009.080958.
7. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360:765-73, doi: 10.1056/NEJMoa0808710.
8. Gravendeel LA, Kloosterhof NK, Bralten LB, van Marion R, Dubbink HJ, Dinjens W, et al. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma. Hum Mutat. 2010;31:E1186-99, doi: 10.1002/humu.21201.
9. Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP, et al. IDH1 mutations at residue p.R132 (IDH1(R132) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat. 2009;30: 7-11, doi: 10.1002/humu.20937.
10. Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Seo SI, et al. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer. 2009;125:353-5, doi: 10.1002/ijc.24379.
11. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807-12, doi: 10.1126/science.1164382.
12. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res. 2009;15:6002-7, doi: 10.1158/1078-0432.CCR-09-0715.
13. Narahara K, Kimura S, Kikkawa K, Takahashi Y, Wakita Y, Kasai R, et al. Probable assignment of soluble isocitrate dehydrogenase (IDH1) to 2q33.3. Hum Genet. 1985;71:37-40, doi: 10.1007/BF00295665.
14. Geisbrecht BV, Gould SJ. The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase. J Biol Chem. 1999;274:30527-33, doi: 10.1074/jbc.274.43.30527.
15. Oba-Shinjo SM, Bengtson MH, Winnischofe SMB, Colin C, Vedoy CG, Mendonça Z, et al. Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis. Mol Brain Res. 2005;140:25-33, doi: 10.1016/j.molbrainres.2005.06.015.
16. Uno M, Oba-Shinjo SM, de Aguiar PH, Leite CC, Rosemberg S, Miura FK, et al. Detection of somatic TP53 splice site mutations in diffuse astrocytomas. Cancer Lett. 2005;224:321-7, doi: 10.1016/j.canlet.2004.10. 022.